We know that ETRM has 13 Health Excellent services plus Mayo clinic which makes it 14 in total so far.
As the infrastructure is already in place and, there is a back log of patients per company awaiting device it means ETRM will come out running.
Lets play with some numbers:
If each center including May has about 700 patients waiting, which is not much per center, it means 10,000 patients to start with at $ 10,000 per device or $ 100 million in revenue.
Of course this is only the start, say there 100 salespeople bring in another 10,000 to 20,000 patients it means up to an additional $ 200 million in sales.
Now that we see some numbers and have idea of market, it won't be long before Wall Street takes notice.
I believe that GSK is preparing a bid for ETRM which will force Medtronic to bid on it too.
Thank-you. I am a type of individual whom will dig in for information just as I first did with my due diligence in ETRM. I have been saying for 1 year that ETRM is a gold mine in a new revolutionary device field and will become a leader. Their technology of rewiring the body to help cure some of the worst medical conditions where pills fail is the wave of the future. ETRM will first attack obesity, then next in line is people with diebetic, those with hypertension, then parkinson, multiple sclerosis, those with organ failures, etc....The applications are endless.
You said that MacDougall Investment has put out a MUST BUY on ETRM with an insane target price for their high worth individuals, estates and institutions they cater to?
Should be fun
Who We Are
MacDougall Investment ...... is the investment counseling arm of 3Macs (MacDougall MacDougall & MacTier). We provide investment management services to high net worth individuals, estates and institutions on a discretionary basis.
MIC is a multiple strategy firm defined by its dedicated personalized services and high ethical standards. Our investment teams are completed by a strong administrative staff supported by the latest portfolio management technology.
We have offices in Montreal and Toronto.
How do you think the name of Enteromedics got into Newsweek. Surely it was not the writer who researched 15,000 public companies. It is ETRM whom is giving PR at the right places. Sure website would be nice but I am seeing that they prefer playing with the big names, which is ok as these big pockets will drive the stock price to insane levels. Next week Canaccord conference is proof of this.
I like the fact that ETRM did say that clinics Health Excellence clinics are already in place and that there is a BACKLOG of patients waiting for the device. This means that ETRM will come out running once device is approved and buyout is probably more of an assurance than speculation.
Those selling now really have no idea of what they are doing. They are joined by the shorts whom are totally lost.
Excellent article. We are at the forefront of new innovation which will move away from all types of pills and instead use devices to cures all types of terrible diseases. I laughed when one rewired a dead person to bring him back to life.
The countless devices which can be developed by ETRM are simply mind boggling for all types of medical disorders.
Those who sold had no idea what they were holding on to.
Timing of article is perfect for Canaccord conference.
If I were SHORTS I would cover, as talking to folks easily opens the door to serious BID. Once one bids then the rest follow and we have BIDDING WAR.
By which ever way, it means either PAY UP BIG or WE MAKE IT BIG on our own, which ever way is necessary.
Medtronic will buy this out as acquistion can be made for $ 7 per share, not costing too much and quickly returning their investment with earnings as market is HUGE, both obese and in $$$$ terms.
Sometimes we have to spell it out for people. ETRM has received expressions of interest from potential acquirers however, Knudson made it clear that he is not giving company away and any offer has to have signficant premium otherwise he will take the market himself.
Is that clear enough?
Talking to FDA on labelling is usually a good sign that approval will be given otherwise talk of this would be premature.
Who are they talking to? Medtronic? I believe that Knudson is asking for significant premium if buyout otherwise they will go to the market themselves as it is $ 210 billion. The infrastructure in terms of doctors, patients, clinics, hospitals and operating tables is already in place. VBLOC will only be manufactured on orders so no cost here until sold. The only outlay is to print some booklets of information and training some medical sales people. Once you have your sales force, they will target the doctors whom will recommend device to their patients. Each doctor whom comes on board will bring in hundreds of patients if not thousands, on some bigger ones.
It is now clear that ETRM wanted to keep the BIG SPLASH for huge POCKETS. Telling those investors that ETRM is entering a $ 210 billion market where they carry a valuation of only $ 88 million as of today will send floods of buyers to this stock.
Those magical words which investors needed to hear "building commercial infrastructure".
This is the next stage where significant value will be added to the stock as we move from science lab work to selling the device. It is earnings which will rock this stock much higher. Entering a $ 210 billion market which a device in which we have NO COMPETITORS and patents. Company needs to lay down a VISION of this commercial infrastructure which is being developed. This will clear the clouds and once investors see better you can expect institutions upon institutions to load up including many upgrades. ETRM should be trading at 4 to 5 times what it is now just on this news alone of commercialization.
ETRM kept the PR splash for the Canaccord audience. It is becoming clearer now. Stock took a beating because of the silence and only encouraged short sellers as longs lost faith that company had no vision and no plans to market the device. They took the silence as confirmation of this.
In the background ETRM was strategizing as to how best to get the word out and it was decided with a Canaccord audience where there are analysts and people have big pockets was the best place to promote their vision. In the audience will be competitors and also people from firms whom may be looking at ETRM.
It does appear that Knudson is about to turn the PR machine on. Reaffirmation of $ 5 price target by Roth Capital when stock is close to $ 1 is pretty gutsy and confident call of the future.
If I were shorts I would cover in a hurry as this will spike up pretty hard as long investors whom sold will return after realizing they made a mistake to sell and, will drive this up aggressively since stock is illiquid and now in strong hands.
Dr. Knudson will provide an overview of EnteroMedics and its development and commercialization program for VBLOC® vagal blocking therapy.
August 14th Canaccord conference. Finally going to get details on commercialization side of the business as approval seems to be a done deal. This will give investors a VISION of the future and a reason to buy a high growth stock. Who knows perhaps this sell off was to permit those attending the conference to come and load up cheaply so Canaccord looks brillant.
Do not over think this. It is easy to get discouraged and say that you did something wrong. There is absolutely nothing wrong with your investment or with the company or with the approval process or with VBLOC for obesity and other devices.
ETRM is a very illiquid stock and therefore there will be huge fluctuations in price one way or the other. The markets have been correcting of late so buyers kind of stay away. It is also the seasonable slow period for obesity market. And institutions may have seen some investor redemption which forced them to sell some shares.
There can be other motives too. I have often seen huge volume on ETRM and price has barely moved. This would indicate wash trades in which there is same buyer and seller. Most people who are not sophisticated will look at volume and get discouraged to sell. It is called shaking the tree. Then longs sell and those whom did wash trades accumulate. This has been going on for 6 weeks since June 17th date.
What I see is ACCUMULATION and not selling from an interested acquirer. It may be Medtronic or someone else. Imagine if they didn't do this, to buy 1 million shares they would have driven the price up to $ 5, another 1 million shares another $ 2 up, and so forth. With wash trades they accumulate large quantities cheaply and then announce huge buyout to rest of shareholders who have endured the abuse.
Most of the trading I say is wash trading which scares longs into selling. On the other end, the ones whom are doing the wash trading to get longs to sell are ACCUMULATING hence why I say there will be a BUYOUT.
Again kudos to you on this one at this TIME. Nothing else you can say will affect or scare people who have been in a typical holocaust here. There is only bones left on people, not even an ounce of fat.
You were right about sell off and so are 8.5 million shorts and put buyers. So you are not that unique. The thing is that you are RIGHT at this moment in time 100%, lets see where we are in 6 months, 1 year, 3 years, 5 years, 10 years and 25 years. I bet we will be much higher than today.
Good, so then I can LOAD UP on Friday at 52 week low, buy low and sell high, right!!!!